, Volume 65, Issue 8, pp 1061–1072

The Role of Topical Retinoids in the Treatment of Photoaging

Therapy in Practice


Aging of the skin is a complex biological process which is influenced by the interaction of several intrinsic and extrinsic factors. Intrinsic or chronological aging is an inevitable, genetically programmed process, of unclear underlying mechanism, for which no prevention or effective treatment is currently available. Photoaging refers to the gross and microscopic cutaneous changes that are induced by cumulative exposure to UV radiation and are superimposed on the background of chronological aging. Although primarily an aesthetic problem with significant psychological effects, photoaging constitutes the background for the development of precancerous and cancerous skin lesions.

Overwhelming clinical and histological evidence indicate that certain structural changes induced by excessive sun exposure can be reversed, to some extent, by the use of topical retinoids. A number of retinoid compounds, for example tretinoin, isotretinoin, retinaldehyde and tazarotene, have been employed for the treatment of photoaged skin, and demonstrate beneficial clinical and histological effects. Adverse effects have been limited to an irritant reaction of variable intensity presenting with dryness, scaling and erythema. Ongoing research will enhance our understanding of the molecular mechanisms that determine the effects of retinoids on photodamaged skin and contribute to the employment of new, more effective and less irritating retinoid compounds.


  1. 1.
    Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 5th ed. New York: McGraw-Hill Professional, 1999: 2810–20Google Scholar
  2. 2.
    Tobin CJ. Retinoids, homeoboxes and growth factors toward molecular models for limb development. Cell 1991; 66: 199–217CrossRefGoogle Scholar
  3. 3.
    Siegenthaler G, Saurat J-H, Ponec M. Retinol and retinal metabolism: relationship to the state of differentiation of cultured human keratinocytes. Biochem J 1990; 268: 371–8PubMedGoogle Scholar
  4. 4.
    Duell EA, Astrom A, Griffiths CEM, et al. Human skin levels of retinoic acid and cytochrome p-450-derived-hydroxyretinoic acid after topical application of retinoic acid receptor-mediated transcription in vitro. J Clin Invest 1992; 90: 1269–74PubMedCrossRefGoogle Scholar
  5. 5.
    Torras H. Retinoids in aging. Dermatol Clin 1996; 14: 207–15CrossRefGoogle Scholar
  6. 6.
    Kligman A, Fulton Jr JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969; 99: 469–76PubMedCrossRefGoogle Scholar
  7. 7.
    Cordero A. La vitamina A acida en la piel senil. Actua Ter Dermatol 1983; 6: 49–54Google Scholar
  8. 8.
    Kligman LH. Effects of all-trans-retinoic acid on the dermis of hairless mice. J Am Acad Dermatol 1986; 15: 779–85PubMedCrossRefGoogle Scholar
  9. 9.
    Kligman AM, Grove GZ, Hirose R, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15: 836–59PubMedCrossRefGoogle Scholar
  10. 10.
    Gilchrest BA. Skin aging 2003: recent advances and current concepts. Cutis 2003; 72 (3 Suppl.): 5–10PubMedGoogle Scholar
  11. 11.
    Fenske NA, Lober CW. Structural and junctional changes of normal aging skin. J Am Acad Dermatol 1986; 15: 571–85PubMedCrossRefGoogle Scholar
  12. 12.
    Montagna W, Carlisle K. Structural changes in aging human skin. J Invest Dermatol 1979; 73: 47–53PubMedCrossRefGoogle Scholar
  13. 13.
    Lavker RM, Zheng PS, Dong G. Aged skin: a study by light, transmission electron and scanning electron microscopy. J Invest Dermatol 1987; 88: 44s-51sCrossRefGoogle Scholar
  14. 14.
    Lavker RM. Cutaneous aging: chronologic versus photoaging. In: Gilchrest BA, editor. Photodamage. Cambridge (MA): Blackwell Science Inc., 1995: 123–35Google Scholar
  15. 15.
    Kligman AM. Early destructive effects of sunlight on human skin. JAMA 1969; 210: 2377–80PubMedCrossRefGoogle Scholar
  16. 16.
    Lavker RM, Kligman AM. Chronic heliodermatitis: a morphologic evaluation of chronic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1988; 90: 325–30PubMedCrossRefGoogle Scholar
  17. 17.
    Astrom A, Tavakkol A, Pettersson U, et al. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 1991; 266: 17662–6PubMedGoogle Scholar
  18. 18.
    Eller MS, Oleksiak MF, McQuaid TJ, et al. The molecular cloning and expression of two CRABP cDNAs from human skin. Exp Cell Res 1992; 199: 328–36CrossRefGoogle Scholar
  19. 19.
    Petkovich M, Brand MJ, Krust A, et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–50PubMedCrossRefGoogle Scholar
  20. 20.
    Brand N, Petkovich M, Krust A, et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850–3PubMedCrossRefGoogle Scholar
  21. 21.
    Krust A, Kastner P, Petkovich M, et al. A third human retinoic acid receptor hRAR-γ. Proc Natl Acad Sci U S A 1989; 86: 5310–4PubMedCrossRefGoogle Scholar
  22. 22.
    Manglesdorf DJ, Ong ES, Dyck JA, et al. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–9CrossRefGoogle Scholar
  23. 23.
    Rees JL, Redfern CPF. Expression of the α and β retinoic acid receptors in skin. J Invest Dermatol 1989; 92: 818–20CrossRefGoogle Scholar
  24. 24.
    Nagpal S, Saunders M, Kastner P, et al. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992; 70: 1007–19PubMedCrossRefGoogle Scholar
  25. 25.
    Gilchrest BA. Retinoids and photodamage. Br J Dermatol 1992; 127 Suppl. 41: 14–20CrossRefGoogle Scholar
  26. 26.
    Griffiths CEM, Voorhees JJ. Effects of retinoids on photodamaged skin. In: Gilchrest BA, editor. Photodamage. Cambridge (MA): Blackwell Science Inc., 1995: 221–43Google Scholar
  27. 27.
    Griffiths CEM, Finkel LJ, Tranfaglia MG, et al. An in vivo experimental model for topical retinoid effects on human skin. Br J Dermatol 1993; 29: 389–99CrossRefGoogle Scholar
  28. 28.
    Fisher GJ, Tavakkol A, Griffiths CEM, et al. Differential modulation of transforming growth factor β1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 1992; 98: 102–8PubMedCrossRefGoogle Scholar
  29. 29.
    Griffiths CEM, Goldfarb MT, Finkel LJ, et al. Topical tretinoin (retinoic acid) treatment for hyperpigmented lesions associated with photoaging in Chinese and Japanese patients. J Am Acad Dermatol 1994; 30: 76–84PubMedCrossRefGoogle Scholar
  30. 30.
    Orlow SJ, Chakraborty AK, Pawalek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990; 94: 461–4PubMedCrossRefGoogle Scholar
  31. 31.
    Kligman AM, Zheng P, Lavker RM. The anatomy and pathogenesis of wrinkles. Br J Dermatol 1985; 113: 37–42PubMedCrossRefGoogle Scholar
  32. 32.
    Griffiths CEM, Russman AN, Majmudar G, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993; 329: 530–5PubMedCrossRefGoogle Scholar
  33. 33.
    Fisher GJ, Wang ZQ, Datta SC, et al. Pahtophysiology of premature skion aging induced by ultraviolet radiation. N Engl J Med 1997; 337: 1419–28PubMedCrossRefGoogle Scholar
  34. 34.
    Weiss JS, Ellis CN, Headington JT, et al. Topical tretinoin improves photoaged skin. JAMA 1988; 259: 527–3PubMedCrossRefGoogle Scholar
  35. 35.
    Leyden JJ, Grove GL, Grove MJ, et al. Treatment of photodamaged skin with topical tretinoin. J Am Acad Dermatol 1989; 21: 638–44PubMedCrossRefGoogle Scholar
  36. 36.
    Lever L, Kumar P, Marks R. Topical retinoic acid for the treatment of solar damage. Br J Dermatol 1990; 122: 91–8PubMedCrossRefGoogle Scholar
  37. 37.
    Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence-based analysis. J Am Acad Dermatol 1998; 39: S55–61PubMedCrossRefGoogle Scholar
  38. 38.
    Griffiths CEM, Kang S, Ellis CN, et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. Arch Dermatol 1995; 131: 1037–44PubMedCrossRefGoogle Scholar
  39. 39.
    Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol 1991; 127: 659–65PubMedCrossRefGoogle Scholar
  40. 40.
    Olsen EA, Katz I, Levine N, et al. Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 1992; 26: 215–24PubMedCrossRefGoogle Scholar
  41. 41.
    Green LJ, McCormick A, Weinstein GD. Photoaging and the skin: the effects of tretinoin. Dermatol Clin 1993; 11: 97–105PubMedGoogle Scholar
  42. 42.
    Ellis CN, Weiss JS, Hamilton TA, et al. Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin. J Am Acad Dermatol 1990; 23: 629–37PubMedCrossRefGoogle Scholar
  43. 43.
    Bhawan J, Olsen E, Lufrano L, et al. Histologic evaluation of the long-term effects of tretinoin on photodamaged skin. J Dermatol Sci 1996; 11: 177–82PubMedCrossRefGoogle Scholar
  44. 44.
    Zelickson AS, Mottz JH, Weiss JS, et al. Topical tretinoin in photoaged skin: an ultrastructural study. J Cut Aging Cosm Dermatol 1988; 1: 41–7Google Scholar
  45. 45.
    Buchan P, Eckhoff C, Caron D, et al. Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in humans. J Am Acad Dermatol 1994; 30: 428–34PubMedCrossRefGoogle Scholar
  46. 46.
    Sendagorta E, Lesiewicz J, Armstrong RB. Topical isotretinoin for photodamaged skin. J Am Acad Dermatol 1992; 27: S15–8PubMedCrossRefGoogle Scholar
  47. 47.
    Maddin S, Lauharanta J, Agache P, et al. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol 2000; 42: 56–63PubMedCrossRefGoogle Scholar
  48. 48.
    Alirezai M, Dupuy R, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447–51PubMedCrossRefGoogle Scholar
  49. 49.
    Saurat JH, Didierjean L, Masgrau E, et al. Topical retinaldehyde on human skin: biological effects and tolerance. J Invest Dermatol 1994; 103: 770–4PubMedCrossRefGoogle Scholar
  50. 50.
    Didierjean L, Tran C, Sorg O, et al. Biological activities of retinaldehyde. Dermatology 1999; 199 Suppl. 1: 19–24CrossRefGoogle Scholar
  51. 51.
    Creidi P, Vienne MP, Ochonisky S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998; 39: 960–5PubMedCrossRefGoogle Scholar
  52. 52.
    Boisnic S, Branchet-Gumila MC, Le Charpentier Y, et al. Repair of UVA-induced elastic fiber and collagen damage by 0.05% retinaldehyde cream in an ex vivo human skin model. Dermatology 1999; 199 Suppl. 1: 43–8CrossRefGoogle Scholar
  53. 53.
    Sefton J, Kligman AM, Kopper SC, et al. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1 % gel. J Am Acad Dermatol 2000; 43: 656–63PubMedCrossRefGoogle Scholar
  54. 54.
    Kang S, Leyden JJ, Lowe NJ. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol 2001; 137: 1597–604PubMedGoogle Scholar
  55. 55.
    Lowe N, Gifford M, Tanghetti E, et al. Tarazotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. J Cosmet Laser Ther 2004; 6: 79–85PubMedCrossRefGoogle Scholar
  56. 56.
    Phillips TJ, Gottlieb AB, Leyden JJ, et al. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Arch Dermatol 2002; 138: 1486–93PubMedCrossRefGoogle Scholar
  57. 57.
    Grove GL, Grove MJ, Leyden JJ, et al. Skin replica analysis of photodamaged skin after therapy with tretinoin emollient cream. J Am Acad Dermatol 1991; 25: 231–7PubMedCrossRefGoogle Scholar
  58. 58.
    Kligman AM, Graham GF. Histological changes in facial skin after daily application oftretinoin for 5 to 6 years. J Dermatol Treat 1993; 4: 113–7CrossRefGoogle Scholar
  59. 59.
    Grove GL, Grove MJ, Zerwick CR, et al. Determination of topical tretinoin effects on cutaneous microcirculation in photoaged skin by laser Doppler velocimetry. J Cut Aging Cosmet Dermatol 1988; 1: 27–33Google Scholar
  60. 60.
    Marks R, Hill S, Barton SP. The effects of an abrasive agent on normal skin and on photodamaged skin in comparison with topical tretinoin. Br J Dermatol 1990; 123: 457–66PubMedCrossRefGoogle Scholar
  61. 61.
    Kligman AM, Dogadkina D, Lavker RM. Effects of topical tretinoin on non-sun-exposed protected skin of the elderly. J Am Acad Dermatol 1993; 39: 25–33CrossRefGoogle Scholar
  62. 62.
    Katsambas AD, Katoulis AC. Topical retinoids in the treatment of aging of the skin. In: Mallia C, Uitto J, editors. RheumaDerm. New York: Kluwer Academic/Plenum Publishers, 1999: 477–82CrossRefGoogle Scholar
  63. 63.
    Ortonne JP, Marks R. The treatment of skin photoaging. In: Ortonne JP, Marks R, editors. Photodamaged skin: clinical signs, causes, management. London: Martin Dunitz Ltd, 1999: 121–42Google Scholar
  64. 64.
    Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003; 42: 1287–304PubMedCrossRefGoogle Scholar
  65. 65.
    Kligman AM. Isotopical tretinoin teratogenic? [letter]. JAMA 1988; 259: 2918Google Scholar
  66. 66.
    Jick SJ, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993; 341: 1181–2PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Alexander J. Stratigos
    • 1
  • Andreas D. Katsambas
    • 1
  1. 1.Department of DermatologyUniversity of Athens School of Medicine, Andreas Sygros HospitalAthensGreece

Personalised recommendations